These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26274923)

  • 21. Intrarenal macrophage infiltration induced by T cells is associated with podocyte injury in lupus nephritis patients.
    Ma R; Jiang W; Li Z; Sun Y; Wei Z
    Lupus; 2016 Dec; 25(14):1577-1586. PubMed ID: 27147620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glomerular basement membrane deposition of collagen α1(III) in Alport glomeruli by mesangial filopodia injures podocytes via aberrant signaling through DDR1 and integrin α2β1.
    Madison J; Wilhelm K; Meehan DT; Delimont D; Samuelson G; Cosgrove D
    J Pathol; 2022 Sep; 258(1):26-37. PubMed ID: 35607980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The contribution of podocytes to chronic allograft nephropathy.
    Pippin J; Kumar V; Stein A; Jablonski P; Shankland SJ; Davis CL
    Nephron Exp Nephrol; 2009; 111(1):e1-10. PubMed ID: 19052472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intra-renal and urinary mRNA expression of podocyte-associated molecules for the estimation of glomerular podocyte loss.
    Wang G; Lai FM; Lai KB; Chow KM; Kwan BC; Li KT; Szeto CC
    Ren Fail; 2010 Jan; 32(3):372-9. PubMed ID: 20370455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome.
    Prodromidi EI; Poulsom R; Jeffery R; Roufosse CA; Pollard PJ; Pusey CD; Cook HT
    Stem Cells; 2006 Nov; 24(11):2448-55. PubMed ID: 16873763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Podocyte injury in pure membranous and proliferative lupus nephritis: distinct underlying mechanisms of proteinuria?
    Rezende GM; Viana VS; Malheiros DM; Borba EF; Silva NA; Silva C; Leon EP; Noronha IL; Bonfa E
    Lupus; 2014 Mar; 23(3):255-62. PubMed ID: 24356611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular and functional characterization of urine-derived podocytes from patients with Alport syndrome.
    Iampietro C; Bellucci L; Arcolino FO; Arigoni M; Alessandri L; Gomez Y; Papadimitriou E; Calogero RA; Cocchi E; Van Den Heuvel L; Levtchenko E; Bussolati B
    J Pathol; 2020 Sep; 252(1):88-100. PubMed ID: 32652570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-glycoside of Tripterygium wilfordii Hook. f. reduces proteinuria through improving podocyte slit diaphragm dysfunction in anti-Thy1.1 glomerulonephritis.
    Wan YG; Sun W; Zhen YJ; Che XY; Pu HP; Wang Y; Li M; Ruan JG; Yan QJ
    J Ethnopharmacol; 2011 Jun; 136(2):322-33. PubMed ID: 21570456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumour necrosis factor-α drives Alport glomerulosclerosis in mice by promoting podocyte apoptosis.
    Ryu M; Mulay SR; Miosge N; Gross O; Anders HJ
    J Pathol; 2012 Jan; 226(1):120-31. PubMed ID: 21953121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of glomerular collagen IV immunofluorescence studies in male patients with X-linked Alport syndrome.
    Massella L; Gangemi C; Giannakakis K; Crisafi A; Faraggiana T; Fallerini C; Renieri A; Muda AO; Emma F
    Clin J Am Soc Nephrol; 2013 May; 8(5):749-55. PubMed ID: 23371956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human Chorionic Stem Cells: Podocyte Differentiation and Potential for the Treatment of Alport Syndrome.
    Moschidou D; Corcelli M; Hau KL; Ekwalla VJ; Behmoaras JV; De Coppi P; David AL; Bou-Gharios G; Cook HT; Pusey CD; Fisk NM; Guillot PV
    Stem Cells Dev; 2016 Mar; 25(5):395-404. PubMed ID: 26728561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathological features of proteinuric nephropathy resembling Alport syndrome in a young Pyrenean Mountain dog.
    Sugahara G; Naito I; Miyagawa Y; Komiyama T; Takemura N; Kobayashi R; Mineshige T; Kamiie J; Shirota K
    J Vet Med Sci; 2015 Sep; 77(9):1175-8. PubMed ID: 25892536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion of von Hippel-Lindau in glomerular podocytes results in glomerular basement membrane thickening, ectopic subepithelial deposition of collagen {alpha}1{alpha}2{alpha}1(IV), expression of neuroglobin, and proteinuria.
    Steenhard BM; Isom K; Stroganova L; St John PL; Zelenchuk A; Freeburg PB; Holzman LB; Abrahamson DR
    Am J Pathol; 2010 Jul; 177(1):84-96. PubMed ID: 20522651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiproteinuric effect of pirfenidone in a rat model of anti-glomerular basement membrane glomerulonephritis.
    Takakura K; Mizukami K; Mitori H; Noto T; Tomura Y
    Eur J Pharmacol; 2014 Aug; 737():106-16. PubMed ID: 24858365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role for macrophage metalloelastase in glomerular basement membrane damage associated with alport syndrome.
    Rao VH; Meehan DT; Delimont D; Nakajima M; Wada T; Gratton MA; Cosgrove D
    Am J Pathol; 2006 Jul; 169(1):32-46. PubMed ID: 16816359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excess podocyte semaphorin-3A leads to glomerular disease involving plexinA1-nephrin interaction.
    Reidy KJ; Aggarwal PK; Jimenez JJ; Thomas DB; Veron D; Tufro A
    Am J Pathol; 2013 Oct; 183(4):1156-1168. PubMed ID: 23954273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal basement membrane alpha 5(IV) expression in females with Alport syndrome and severity of renal disease.
    Massella L; Onetti Muda A; Faraggiana T; Bette C; Renieri A; Rizzoni G
    Kidney Int; 2003 Nov; 64(5):1787-91. PubMed ID: 14531812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary podocyte and TGF-β1 mRNA as markers for disease activity and progression in anti-glomerular basement membrane nephritis.
    Fukuda A; Minakawa A; Sato Y; Iwakiri T; Iwatsubo S; Komatsu H; Kikuchi M; Kitamura K; Wiggins RC; Fujimoto S
    Nephrol Dial Transplant; 2017 Nov; 32(11):1818-1830. PubMed ID: 28419296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nephron, Wilms' tumor-1 (WT1), and synaptopodin expression in developing podocytes of mice.
    Kato T; Mizuno S
    Exp Anim; 2017 Aug; 66(3):183-189. PubMed ID: 28179596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shp2 Associates with and Enhances Nephrin Tyrosine Phosphorylation and Is Necessary for Foot Process Spreading in Mouse Models of Podocyte Injury.
    Verma R; Venkatareddy M; Kalinowski A; Patel SR; Salant DJ; Garg P
    Mol Cell Biol; 2016 Feb; 36(4):596-614. PubMed ID: 26644409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.